Standout Papers

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and IN... 2016 2026 2019 2022 320
  1. Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials (2016)
    Luca Richeldi, Vincent Cottin et al. Respiratory Medicine

Immediate Impact

2 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
2 intermediate papers

Works of Zelie Bailes being referenced

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
2020
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
2016 Standout

Author Peers

Author Last Decade Papers Cites
Zelie Bailes 510 342 44 63 16 588
Bridget F. Collins 508 231 23 121 24 674
Xavier Jaumont 184 307 51 96 18 737
Markku Turpeinen 444 371 22 16 13 661
Akihisa Uemura 340 384 15 79 24 722
Christoph Hallmann 557 378 15 58 18 615
Alexandra M. Nanzer 419 492 82 69 19 674
A Ellison 254 108 43 45 11 687
Nikos M. Siafakas 347 161 6 19 18 550
Margrét B. Andrésdóttir 177 101 28 14 20 734
Sally Hamour 303 61 11 151 19 568

All Works

Loading papers...

Rankless by CCL
2026